Follow-up Study of AAV-Mediated Gene Transfer (UX111; Previously Known as ABO-102) for MPS Type IIIA

Clinical trial NCT04360265 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT04360265
Sponsor: Ultragenyx Pharmaceutical Inc
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Mucopolysaccharidosis IIIA MPS IIIA Sanfilippo Syndrome Sanfilippo A

Start date: 2020-09-28
Primary completion: 2027-08-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.